"ctDNA as a minimal residual disease biomarker after curative-intent pancreatic cancer resection" OR "ctDNA as a prognostic biomarker after curative-intent pancreatic cancer resection — systematic review and meta-analysis" would you recommend the below to be a good meta-analysis focused topic with good impact and feasibility
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.